Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering
Go back to Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 284.52 -3.33 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.85 | 52 Week High | $139.79 | |||
| Open | $284.71 | 52 Week Low | $82.07 | |||
| Day High | $289.20 | P/E | 661.67 | |||
| Day Low | $282.40 | EPS | $0.43 | |||
| Volume | 206,325 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.86 -0.52 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.38 | 52 Week High | $5.17 | |||
| Open | $34.33 | 52 Week Low | $0.94 | |||
| Day High | $34.39 | P/E | N/A | |||
| Day Low | $33.15 | EPS | $0.00 | |||
| Volume | 2,206,997 | |||||
